Skip to main content
Livermore
Livermore
ZHEN

Barclays PLC

SEC CIK
0000312069
Latest filing
Aug 14, 2026

AZN holding history

AstraZeneca PLC in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AZN overviewAll 13F holders of AZNFull Q2 2026 holdings

Shares (Q2 2026)
6,592,403
Value
$1.25B
% of portfolio
0.4%
Quarters held
22
Since Q1 2021
Holdings of AZN by Barclays PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,592,403$1.25B0.4%+1,100,411+20.0%AddedHolders
Q1 20265,491,992$1.08B0.4%+4,119,191+300.1%AddedConverted for a 1-for-2 splitHolders
Q4 20252,745,603$252.4M0.1%+2,058,077+299.3%AddedHolders
Q3 2025687,526$52.7M<0.1%+6,874+1.0%AddedHolders
Q2 2025680,652$47.6M<0.1%+92,556+15.7%AddedHolders
Q1 2025588,096$43.2M<0.1%−476,806−44.8%ReducedHolders
Q4 20241,064,902$69.8M<0.1%+602,652+130.4%AddedHolders
Q3 2024462,250$36.0M<0.1%−30,667−6.2%ReducedHolders
Q2 2024492,917$38.4M<0.1%−399,632−44.8%ReducedHolders
Q1 2024892,549$60.5M<0.1%+232,498+35.2%AddedHolders
Q4 2023660,051$44.5M<0.1%−582,380−46.9%ReducedHolders
Q3 20231,242,431$84.1M0.1%+944,765+317.4%AddedHolders
Q2 2023297,666$21.3M<0.1%−9,162−3.0%ReducedHolders
Q1 2023306,828$21.3M<0.1%−42,633−12.2%ReducedHolders
Q4 2022349,461$23.7M<0.1%+225,731+182.4%AddedHolders
Q3 2022123,730$6.79M<0.1%−98,798−44.4%ReducedHolders
Q2 2022222,528$14.7M<0.1%+205,620+1,216.1%AddedHolders
Q1 202216,908$1.12M<0.1%−402,616−96.0%ReducedHolders
Q4 2021419,524$24.4M<0.1%+404,405+2,674.8%AddedHolders
Q3 202115,119$908.0K<0.1%−396,317−96.3%ReducedHolders
Q2 2021411,436$24.6M<0.1%+411,027+100,495.6%AddedHolders
Q1 2021409$20.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.